Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 1/20 | 0.45 |
| ▸ | PTGDR2 | Q9Y5Y4 | 11/20 | 0.44 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.41 |
| ▸ | TACR1 | P25103 | 1/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.39 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.39 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.38 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.38 |
| ▸ | CETP | P11597 | 2/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | PPARD | Q03181 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL41599 | 0.89 | SCN9A (0.47) | SCN9APTGDR2MCHR1TACR1TBXA2R | |
| SCHEMBL9145008 | 0.81 | PDE4B (0.43) | SCN9APTGDR2MCHR1PDE4B | |
| SCHEMBL6061977 | 0.79 | PDE4B (0.58) | SCN9APTGDR2MCHR1TBXA2RPTGDR | |
| SCHEMBL3694425 | 0.74 | CETP (0.43) | SCN9APTGDR2MCHR1TACR1TBXA2R | |
| SCHEMBL30002156 | 0.74 | HDAC3 (0.49) | PTGDR2CETPPDE4BPPARDPPARA | |
| SCHEMBL4064597 | 0.74 | HDAC3 (0.49) | PTGDR2CETPPDE4BPPARDPPARA | |
| SCHEMBL9147697 | 0.72 | PDE4B (0.43) | SCN9APTGDR2MCHR1TACR1PDE4B | |
| SCHEMBL8997635 | 0.71 | HTT (0.51) | PTGDR2 | |
| SCHEMBL1395234 | 0.71 | KDM4E (0.51) | PTGDR2AKR1C3AKR1C2 | |
| SCHEMBL9145484 | 0.71 | PDE4B (0.53) | SCN9APTGDR2MCHR1TBXA2RPTGDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080103144-A1 | Fungicidal mixtures based on amide compounds and morpholine or piperidine derivatives | SCHELBERGER KLAUS | 2008-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103144-A1 | Fungicidal mixtures based on amide compounds and morpholine or piperidine derivatives | OPRM1, SIGMAR1, CYP3A4 | SCN9A 543/4885PTGDR2 1150/4885MCHR1 320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.